The worldwide shortage of donor corneas and postoperative complications present challenges to surgically treating children who are blind from CHED. Therefore, a clearer understanding of disease mechanisms that underlie CHED is needed in an effort to develop alternative treatments (e.g. gene based therapeutics) that will improve patient outcomes and decrease the dependence on donor cornea tissue.
Read MoreDr Aaron Nagiel, featured in this article, from the Vision Center, Children’s Hospital Los Angeles, received a Knights Templar Eye Foundation Starter Grant in 2018
Read MoreIt is indeed a high honor to be addressing each of you today as the Chairman for the 52nd Annual Knights Templar Eye Foundation Voluntary Campaign! As Knights Templar, there are many great and wonderful things that we do; perhaps none more so than diligently working towards the end goal of the gift of sight. As Masons, we should always be searching for Light, and how exciting it is for us as Knights Templar to help bring Light to others through our gifts to the Knights Templar Eye Foundation, Inc.
Read MoreThe Association for Research in Vision and Ophthalmology (ARVO) has awarded 95 travel grants this year to help student/trainee members attend the 2019 annual meeting in Vancouver, Canada, thanks to a grant to the ARVO Foundation for Eye Research from the Knights Templar Eye Foundation, Inc. (KTEF)
Read More
